2022. PSA-IgM and iXip in the diagnosis and management of prostate cancer: clinical relevance and future potential. A review. Acta Biomedica Atenei Parmensis. 92, 6 (Jan. 2022), e2021344. DOI:https://doi.org/10.23750/abm.v92i6.12058.